Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice
- PMID: 15665282
Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice
Abstract
Fanconi anemia (FA) is an autosomal recessive disease characterized by progressive bone marrow failure and an increased susceptibility to cancer. FA is genetically heterogeneous, consisting of at least 11 complementation groups, FA-A through L, including FA-D1 (BRCA2) and D2. We have previously reported an increased incidence of epithelial tumors in Fancd2 knockout mice. To further investigate the role of the FA pathway in tumor prevention, Fancd2 mutant mice were crossed to mice with a null mutation in the tumor suppressor gene, Trp53. The tumor spectrum in Fancd2(-/-)/Trp53(+/-) mice included sarcomas expected in Trp53 heterozygotes, as well as mammary and lung adenocarcinomas that occur rarely in Trp53 heterozygotes. These tumors occurred earlier than in Fancd2(-/-) control mice. Therefore, the Fancd2(-/-)/Trp53(+/-) mice represent an improved model for the study of adenocarcinoma in FA. In addition, it was found that Fancd2(-/-) mouse embryonic fibroblasts but not Fancd2(-/-)/Trp53(-/-) mouse embryonic fibroblasts arrest following DNA damage. Therefore, Trp53 is required for the S phase checkpoint activation observed in Fancd2 mutant cells. Fancd2(-/-)/Trp53(-/-) cells showed an increase in aneuploidy and had multiple gross chromosomal rearrangements.
Similar articles
-
Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.Cancer Res. 2003 Dec 15;63(24):8596-9. Cancer Res. 2003. PMID: 14695169
-
FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.Oncogene. 2008 Jun 12;27(26):3641-52. doi: 10.1038/sj.onc.1211034. Epub 2008 Jan 21. Oncogene. 2008. PMID: 18212739
-
Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.Hum Mol Genet. 2003 Oct 1;12(19):2503-10. doi: 10.1093/hmg/ddg266. Epub 2003 Aug 5. Hum Mol Genet. 2003. PMID: 12915460
-
The interplay of Fanconi anemia proteins in the DNA damage response.DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1063-9. doi: 10.1016/j.dnarep.2004.04.005. DNA Repair (Amst). 2004. PMID: 15279794 Review.
-
"Dub"bing a tumor suppressor pathway.Cancer Cell. 2005 Feb;7(2):114-5. doi: 10.1016/j.ccr.2005.01.018. Cancer Cell. 2005. PMID: 15710323 Review.
Cited by
-
Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.Blood. 2010 Oct 21;116(16):2915-20. doi: 10.1182/blood-2009-08-240747. Epub 2010 Jul 6. Blood. 2010. PMID: 20606166 Free PMC article.
-
Fanconi anemia proteins and endogenous stresses.Mutat Res. 2009 Jul 31;668(1-2):42-53. doi: 10.1016/j.mrfmmm.2009.03.013. Mutat Res. 2009. PMID: 19774700 Free PMC article.
-
Replication stress and cancer.Nat Rev Cancer. 2015 May;15(5):276-89. doi: 10.1038/nrc3916. Nat Rev Cancer. 2015. PMID: 25907220 Review.
-
Mammalian Resilience Revealed by a Comparison of Human Diseases and Mouse Models Associated With DNA Helicase Deficiencies.Front Mol Biosci. 2022 Aug 11;9:934042. doi: 10.3389/fmolb.2022.934042. eCollection 2022. Front Mol Biosci. 2022. PMID: 36032672 Free PMC article. Review.
-
Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models.Dis Model Mech. 2013 Jan;6(1):40-7. doi: 10.1242/dmm.009795. Dis Model Mech. 2013. PMID: 23268537 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous